Progress in Mass Drug Administration
In the first half of FY 2013, preventive chemotherapy (PCT) was provided as follows:
- Burkina Faso: four (4) districts were treated for LF-oncho-STH with support from the Liverpool Center for Neglected Tropical Diseases (CNTD), and 21 districts were treated for SCH with USAID support, reaching over 598,000 and 2.3 million people, respectively.
- Sierra Leone: Overall, 14 districts were treated for LF-STH; 12 districts were treated for oncho; and 7 districts were treated for SCH. Specific treatments included: 1.3 million people were treated for LF-STH in 2 districts in the Western Area; 1.8 million people in 7 districts were treated for SCH; and 12 districts were treated for LF-oncho-STH.
- Togo: With support from the Government of Togo, 11 districts were treated for oncho and 4 districts for STH; in addition, 1 district was treated for SCH with USAID support. In FY 2013, Togo’s NTDCP is targeting areas in which STH prevalence ≥50%.
- Ghana: MDAs were conducted in 40 districts and at least 494,697 people (partial results) were treated for oncho in the first half of FY 2013, with support from Sightsavers, the Government of Ghana, CNTD Liverpool and the African Program for Onchocerciasis Control (APOC). In addition, MDA was given to at least 2.7 million people (partial results) in 126 districts for SCH with USAID funds; and at least 1,823 people (partial results) out of the 6,053 who were targeted, received MDA for trachoma using funding from Sightsavers.
- Niger: Some 9.6 million people were treated for STH and 4.1 million were treated for SCH in 37 districts. In addition, an estimated 9 million people in 30 districts were treated for LF and 5.2 million were treated in 16 districts for trachoma. All the above MDAs were funded by USAID.
END in Africa, MDA data reports since the inception of the program in 2011, by country
Note: MDA mass drug administration
Partial results of USAID-Supported MDA in FY2011-2012
|Country||Drugs Delivered||Number of Districts Treated||Number of Persons Treated (Millions)||Number of Treatments Delivered (Millions)||Program Coverage Percent (Range)|
|Burkina Faso (2011-2012)||IVM, ALB, PZQ, Zithro, Tetra||45||20.8||39.9**||81-107|
|Niger (2011)||IVM, ALB, PZQ, Zithro, Tetra||35||8.6||20.4**||72-95|
|Sierra Leone (2012)||IVM, ALB||12||3.9||7.8||97.7|
|Ghana (2012)||IVM, ALB||121||8.0||13.9||56.5-92.9|
|Togo (2012)||IVM, ALB, PZQ||30||2.7||7.0||51-99.8|
|Total||IVM, ALB, PZQ, Zithro, Tetra||243||44.4||89.1||NA|
Notes:USAID United States Agency for International Development; MDA mass drug administration; IVM
ivermectin; ALB Albendazole; PZQ Praziquantel; Zithro Azithromycin; Tetra Tetracycline.
Figures may not add due to rounding.
** 2012 Mass Drug Administration for Schistosomiasis not included
*** Totals do not include 2012 Mass Drug Administration data for Togo and the two districts in Western Area, Sierra Leone.
MDA Program and Epidemiological Coverage by country and NTD, available data for FY2012
|Country||NTDs||Program coverage (%)||Epi Coverage (%)|
|STH||Data not yet reported||96.2|
Notes: MDA mass drug administration; NTD neglected tropical diseases; Epi epidemiological; : LF
lymphatic filariasis; Oncho onchocerciasis; SCH schistosomiasis; STH soil-transmitted helminthes; NA not
* The population at-risk for Oncho was initially overestimated by a factor of 7 times
** Only 18 districts treated to date
Available data on PCT updates by treatment provided by country during October 2012 – March 2013
|Drug||Burkina Faso||Ghana****||Togo||Niger||Sierra Leone|
Notes: PCT preventive chemotherapy; MDA mass drug administration; IVM ivermectin; ALB
Albendazole; PZQ Praziquantel; Azy-Tetra: Azithromycin and Tetracycline
*Funded by Center for Neglected Tropical Diseases (CNTD), Liverpool, UK
**598,000 treatments funded by CNTD
***Partial data from 12 districts, treatments funded by Sightsavers and the African Programme for Onchocerciasis Control (APOC)
****No data received from 16 districts; incomplete data received from 26 districts.
*****Partial data; data not yet collated in 12 districts.
******11 districts treated using funding from the Government of Togo; treatment data not currently available.
Number of districts mapped coupled with districts requiring mapping as of FY2012 by NTDs
Countries: Burkina Faso, Ghana, Niger, Sierra Leone, Togo
Notes: LF lymphatic filariasis; Oncho onchocerciasis; SCH schistosomiasis; STH soil-transmitted helminths
Training conducted during April – September 2012
|Trainee cadre||Number Trained|
|MoH employees at central level||66|
|Trainers (Training of trainers)||431|
|Community Drug Distributors||68,414|
Training sessions were cascaded and organized mainly for the MDA activities.
In order to measure the impact of MDA on disease prevalence, the NTD Control Program supports disease-specific assessments at defined intervals in line with WHO guidelines. The status of disease-specific assessments is depicted by countries in the tables below:
Assessments conducted in April – September 2012
(by country, type of assessment and disease)
|Sentinel Site (a)/Pre-TAS||TAS||District level Impact assessment||Sentinel site assessment|
|# Districts Assessed||# Districts prevalence below 1%||# Districts Assessed||# Districts prevalence below 1%||# Districts Assessed||# Districts prevalence below 10%||# Districts Assessed||Median Prev. Baseline (%)||Actual Median prevalence (%)|
|Burkina Faso||3||3||14**||14||11||11||9 (4 rounds treatment)||29 (11.7-45.3)||21 (3-54)|
|Niger||9 (a)||Analysis underway||0||0||2||0||0||NA||NA|
Notes: LF, lymphatic filariasis; Oncho, onchocerciasis; SCH, schistosomiasis; STH, soil-transmitted helminthes; TAS, transmission assessment surveys; Prev., prevalence; NA, not applicable
*Oncho and STH not included
** 9 with USAID funds
*** Post MDA surveillance
Photo Credit: neglecteddiseases.gov
- Financial analysis, advocacy key to raising resources for #NTD morbidity management @DeloitteGov @fhi360… https://t.co/X44paPcDOw
- @ENDinAfrica award for program excellence highlights progress on #NTDs https://t.co/tkfyyOsTp4 @fhi360 #BeatNTDs
- RT @RTIfightsNTDs: Congrats Togo, 1st in sub-Saharan Africa to eliminate lymphatic filariasis! Proud of MOH & partners @USAIDGH @ENDinAfric…